Danish drugmaker Novo Nordisk (NVO), a top competitor to American pharmaceutical giant Eli Lilly (LLY), is currently exciting investors in Europe. The company’s stock price is up about 2% to $57.7 (DKK 365.35) as of 10:33 a.m. EDT on the Nasdaq Copenhagen Stock Exchange. On Germany’s Xetra, the shares also rose by 2.36% to $57 (EUR 48.94) as of 10:30 …
Read More »
U.S. pharmaceutical giant Eli Lilly (LLY) says it is preparing for the approval and launch of its new weight loss pill following the results of a late-stage clinical trial. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The Indianapolis, Indiana-based …
Read More »
Eli Lilly and Company (NYSE:LLY) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On July 30, the company announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study, demonstrating that participants treated with Kisunla (donanemab-azbt) showcased slowing of decline, a benefit which continued to grow over 3 years as compared to an untreated external …
Read More »
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 sales guidance to $60 billion …
Read More »